J

Janssen Pharmaceuticals | Clinical Pharmacology Unit

Research site
(Unclaimed)
Location
Lange Bremstraat 70, Merksem, Antwerpen, Belgium
Site insights

Top conditions

Escherichia coli Infections (1 trial)

Ulcerative Colitis (1 trial)

Crohn Disease (1 trial)

Ulcer (1 trial)

Depression (1 trial)

Top treatments

Macitentan
Itraconazole
JNJ-70033093
JNJ-67953964
Lumicitabine
JNJ-64140284
JNJ-64041575
Erdafitinib
JNJ-56136379
JNJ-55308942

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

1 of 53
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health

The purpose of this study is to assess the safety, reactogenicity, and immunogenicity of 3 different doses of ExPEC10V and to select the optimal dose...

Active, not recruiting
Extraintestinal Pathogenic Escherichia Coli Prevention
Biological: ExPEC4V
Biological: Prevnar 13

Trial sponsors

Janssen logo

Janssen (39 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems